CEO Executive AssistantPrior authorization, the requirement that providers obtain payer approval before delivering certain services, has become one of the most operationally burdensome and clinically consequential administrative processes in healthcare. The volume of services requiring prior authorization has grown substantially over the past decade, consuming significant staff time, delaying care, and contributing to physician burnout. For CEOs of health systems, physician groups, hospitals, and ambulatory care organizations, managing prior authorization operations effectively is both a financial imperative and a patient care quality issue. Building streamlined prior authorization operations requires investment in technology, staffing, payer relationship management, and advocacy for systemic change.
Understanding Prior Authorization’s Operational Impact
Prior authorization requirements affect virtually every clinical department and service line: diagnostic imaging, specialty medications, elective surgical procedures, durable medical equipment, behavioral health services, and more. Each authorization request requires staff to identify authorization requirements, gather and submit supporting clinical documentation, follow up with payers on pending decisions, and manage appeals when requests are denied.
The administrative costs of prior authorization are substantial. The American Medical Association’s annual prior authorization physician survey consistently documents that physicians and their staff spend hours each week on prior authorization tasks, with significant percentages reporting that prior authorization requirements delay or interrupt care, cause patients to abandon recommended treatments, and contribute to adverse clinical outcomes.
CEOs must quantify the operational cost of prior authorization in their organization, including staff time, denial-related revenue loss, and the opportunity cost of clinician time spent on administrative tasks rather than patient care. This quantification provides the business case for operational investments in prior authorization efficiency and for advocacy efforts to reduce unnecessary authorization requirements.
Prior Authorization Operations Infrastructure
Effective prior authorization operations require a combination of trained staff, supporting technology, and well-designed workflows. CEOs should evaluate their prior authorization infrastructure systematically and invest in capabilities that reduce processing time, improve approval rates, and minimize staff burden.
Dedicated prior authorization specialists, staff whose primary function is managing authorization requests, achieve higher efficiency and accuracy than clinical staff who perform authorization as a secondary task. CEOs should evaluate whether the volume of authorization requests in their organization justifies dedicated prior authorization staffing and should assess the productivity and quality metrics of their current authorization operations.
Authorization requirements databases and decision-support tools that automatically identify which services require authorization, pull current payer-specific requirements, and prompt staff to gather the specific documentation needed for each authorization type significantly reduce the time spent researching requirements and the rate of incomplete submissions. CEOs should invest in these tools and ensure they are kept current as payer requirements change.
Technology integration between the prior authorization function, the EHR, and payer portals streamlines the workflow by enabling electronic submission, real-time authorization status updates, and automated alerts for pending authorizations. CEOs should assess the extent to which their current systems support electronic prior authorization (ePA) and should prioritize integration investments that reduce manual work.
For strategic guidance on healthcare operations management, see the healthcare operations guide.
Managing Payer Relationships Strategically
Payer relationships affect prior authorization operations in multiple ways: the volume and scope of authorization requirements, the timeliness and transparency of authorization decisions, the quality of the appeals process, and the overall administrative experience of working with each payer. CEOs should manage major payer relationships strategically, not just at the contract level, but across the operational dimensions that affect daily operations.
Designated payer account managers or provider relations representatives are the relationship owners for major commercial payer contracts. CEOs should ensure that their organization has clear accountability for managing these relationships, that relationship managers engage proactively with payer contacts rather than only when problems arise, and that payer performance is assessed regularly across multiple dimensions including authorization turnaround times, denial rates, and appeals outcomes.
Value-based contract arrangements that shift reimbursement from fee-for-service to risk-based or quality-linked models often reduce prior authorization volume as payers extend greater clinical autonomy to providers who have demonstrated appropriate care management. CEOs should consider the impact of value-based contracting on administrative burden, including prior authorization, when evaluating the full economics of contract arrangements.
Technology and Automation in Prior Authorization
The prior authorization process is well-suited for technology automation due to its structured, rule-based nature. CEOs should invest in technology that automates the most time-consuming and routine elements of authorization management.
Electronic prior authorization (ePA) standards developed by CAKC (Confluence of Automation of Knowledge Center) and NCPDP (for pharmacy authorizations) enable electronic exchange of authorization requests and decisions between providers and payers through standardized interfaces. CEOs should ensure that their EHR and practice management systems support these standards and that electronic authorization is used for all payers who support it.
Artificial intelligence applications for prior authorization are emerging rapidly. AI-powered tools can review clinical documentation, identify the relevant clinical information needed for an authorization request, and pre-populate submission forms. Some AI tools can predict the likelihood of approval based on the clinical scenario and payer rules, enabling proactive identification of likely denials and targeted clinical documentation improvement. CEOs should evaluate these emerging capabilities and invest in those with demonstrated value.
Real-time benefit checks (RTBC) for medications enable prescribers to see formulary status, cost, and authorization requirements at the point of prescribing, enabling earlier identification of drugs that will require prior authorization and facilitating prescribing decisions that minimize authorization burden for patients.
Denial Prevention and Appeals Management
Prior authorization denials represent revenue at risk and potential delays in care. CEOs should track denial rates by payer, service type, and denial reason category and should invest in denial prevention strategies that address the root causes of preventable denials.
Clinical documentation quality is the most common root cause of prior authorization denials. When supporting documentation does not clearly establish medical necessity according to the payer’s clinical criteria, denial is likely. CEOs should establish clinical documentation improvement programs that educate clinicians on payer medical necessity criteria for commonly requested services and that systematically review documentation quality before submission.
Appeals management requires clinical expertise and knowledge of payer-specific appeals procedures. Peer-to-peer review requests, where the treating physician speaks directly with the payer’s reviewing physician, are often the most effective approach for overturning denials based on medical necessity. CEOs should establish peer-to-peer review workflows that make it easy for treating physicians to request and complete peer-to-peer calls in a timely manner.
Gold carding programs, offered by some payers for providers with consistently high authorization approval rates, exempt pre-approved providers from routine prior authorization requirements for specific services. CEOs should track approval rates and pursue gold card arrangements with payers who offer them, as they can significantly reduce operational burden.
Patient Impact and Care Continuity
Prior authorization delays and denials have direct impacts on patient care. CMS and state insurance regulators have established requirements for authorization decision turnaround times, including expedited timelines for urgent clinical situations. CEOs should ensure that their authorization operations are equipped to identify urgent requests and to escalate them appropriately.
Patient advocacy around prior authorization denials is an important patient experience and care quality function. When a patient’s recommended treatment is denied, the care team must have clear processes for communicating with the patient, managing the care plan in the interim, and pursuing appeals. CEOs should ensure that these processes are defined and that patients are not left without care guidance during the appeals process.
For an operational checklist covering prior authorization and other healthcare CEO priorities, the healthcare CEO checklist provides actionable guidance.
Policy Advocacy and Industry Reform
The prior authorization burden on providers and patients has become a major policy issue, driving legislative and regulatory action at both federal and state levels. The Improving Seniors’ Timely Access to Care Act and various state laws have established requirements for Medicare Advantage plans and commercial insurers to implement electronic prior authorization, establish clear timelines for decisions, and limit unnecessary authorization requirements.
CEOs should engage in policy advocacy efforts, through their hospital associations, medical specialty societies, and direct engagement with legislators and regulators, to advance prior authorization reform. The data that healthcare organizations collect on authorization burden, denial rates, and patient care impacts provides powerful evidence for policy arguments.
Reducing unnecessary prior authorization burden serves patients, providers, and ultimately payers, who also bear administrative costs. CEOs who engage constructively with payers on reducing low-value authorization requirements, while maintaining appropriate utilization management for high-cost, high-variation services, can make meaningful progress in reducing the operational burden that consumes billions of healthcare dollars each year.
Related Reading
For further context, explore Healthcare CEO Business Operations Checklist and Healthcare CEO Business Operations for Accountable Care Organizations.